NeurATRIS NeurATRIS
  • English version
  • Version Française

  • Home

    Home

  • NeurATRIS

    NeurATRIS

    • Who are we ?

      Who are we ?

    • Objectives: Research and Services

      Objectives: Research and Services

    • Management

      Management

    • NeurATRIS Network

      NeurATRIS Network

      • Institutional network

        Institutional network

      • Scientific and medical network

        Scientific and medical network

  • Research Programs

    Research Programs

    • Cellular therapies

      Cellular therapies

    • Gene therapies

      Gene therapies

    • In vivo evaluation and therapeutic efficacy

      In vivo evaluation and therapeutic efficacy

    • Drug therapies

      Drug therapies

  • The NeurATRIS Offer

    The NeurATRIS Offer

    • NeurAtris' actions

      NeurAtris' actions

      • Training support

        Training support

      • Research support

        Research support

      • Scientific events

        Scientific events

    • Our tools

      Our tools

      • ALZHEIMER

        ALZHEIMER

      • PARKINSON

        PARKINSON

      • HUNTINGTON DESEASE

        HUNTINGTON DESEASE

      • MULTIPLE SCLEROSIS

        MULTIPLE SCLEROSIS

      • NEURODEVELOPMENTAL DISORDERS

        NEURODEVELOPMENTAL DISORDERS

    • NeurAtris platforms

      NeurAtris platforms

      • NeurAtris platforms

        NeurAtris platforms

      • CEA Paris- Saclay / MIRCen platforms

        CEA Paris- Saclay / MIRCen platforms

      • ICM platforms - GHU Pitié Salpêtrière

        ICM platforms - GHU Pitié Salpêtrière

      • Henri Mondor Hospital platforms

        Henri Mondor Hospital platforms

      • N-BIPS Bicêtre Hospital Platforms

        N-BIPS Bicêtre Hospital Platforms

      • Oniris Nantes / INRAE platforms

        Oniris Nantes / INRAE platforms

      • Robert-Debré Hospital/NeuroDiderot platforms

        Robert-Debré Hospital/NeuroDiderot platforms

      • IStem Platforms

        IStem Platforms

    • A continuum in translational research

      A continuum in translational research

    • How to collaborate

      How to collaborate

    • Submit a project

      Submit a project

  • EATRIS

    EATRIS

  • Home
  • NeurATRIS
    • Who are we ?
    • Objectives: Research and Services
    • Management
    • NeurATRIS Network
      • Institutional network
      • Scientific and medical network
  • Research Programs
    • Cellular therapies
    • Gene therapies
    • In vivo evaluation and therapeutic efficacy
    • Drug therapies
  • The NeurATRIS Offer
    • NeurAtris' actions
      • Training support
      • Research support
      • Scientific events
    • Our tools
      • ALZHEIMER
      • PARKINSON
      • HUNTINGTON DESEASE
      • MULTIPLE SCLEROSIS
      • NEURODEVELOPMENTAL DISORDERS
    • NeurAtris platforms
      • NeurAtris platforms
      • CEA Paris- Saclay / MIRCen platforms
      • ICM platforms - GHU Pitié Salpêtrière
      • Henri Mondor Hospital platforms
      • N-BIPS Bicêtre Hospital Platforms
      • Oniris Nantes / INRAE platforms
      • Robert-Debré Hospital/NeuroDiderot platforms
      • IStem Platforms
    • A continuum in translational research
    • How to collaborate
    • Submit a project
  • EATRIS
  • News
  • Schedule
  • Contact
  1. Home >
  2. News

NeurATRIS supports the 6th SFRMBM congress

NeurATRIS supports the 6th scientific congress of the French Society of Magnetic Resonance in Biology and Medicine (SFRMBM), organized from March 27 to 29, 2023 at the International Conference Center of Sorbonne University, in Paris, as well as the participation of its students/young researchers, by covering their registration fees.

This congress will be an opportunity to review methodological advances and innovative applications in magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS). The work that will be presented covers developments in physics and technology, preclinical applications on small animals, new approaches in signal processing and clinical applications. This multidisciplinary conference aims to bring together physicists, chemists, biologists, computer scientists and clinical physicians in the field of health technologies.

Created: 13 February 2023

Neuratris wishes you a happy holiday season

NeurATRIS wishes you a happy holiday season.

Created: 20 December 2022

NeurATRIS supports the 2023 edition of NeuroLabs

As part of its support to students' training, NeurATRIS supports the organization of the second edition of NeuroLabs, which will take place on January 12, 2023, at the Auditiorium of the Pierre and Marie Curie Campus. Two renowned scientists will participate to this edition: Etienne Hirsch (ICM) and Laure Rondi-Reig (IBPS)

The main objective of this mini-colloquium is to introduce the neuroscience laboratories affiliated to Sorbonne University to the students of the BIP Master, in order to give them an overview of the different teams in which they could do their PhD. This event also allows the students to think about their future and to gain confidence by discussing with the different members of the laboratories.
 

Created: 20 December 2022

A. Lloyd as guest lecturer in a NeurATRIS course - January 06, 2023

As part of NeurATRIS' support to students' training, Professor Alison Lloyd from the Laboratory of Molecular and Cellular Biology at the University College London will give a lecture on January 06, 2023 to the students of the Master 2 BIP. This lecture will focus on peripheral nerve regeneration and will be followed by a discussion and lunch with students. All NeurATRIS members are welcome.

 

Created: 20 December 2022

Next Generation challenge de NeurATRIS- Edition 2022: Congratulations to Pauline Léal

Congratulations to Pauline Léal, 3rd year PhD student at CEA MIRCen (under the supervision of Alexis Bemelmans), who won the NeurATRIS prize for the best oral communication, during the "Next Generation" challenge organized at the NeurATRIS Translational Neuroscience Day, on December 06, 2022.

Her presentation was entitled: "Development of an AAV-based model of tauopathy targeting the dentate gyrus to study the role of microglia in the spreading of toxic tau species". 

     

Created: 20 December 2022

NeurATRIS 2022 days on December 05 and 06 - Cité Internationale Universitaire de Paris

We are very pleased to have gathered the NeurATRIS community again on December 5 and 6, 2022 for the General Assembly of our infrastructure and the Translational Neuroscience Day co-organized with Celphedia.

Thanks to EATRIS for their presence and their active participation in these two days.

Thanks to all speakers and participants.

    

    

       

Created: 20 December 2022

L’Ecole Normale Supérieure (ENS) Paris offers 2 Post-Doc/ Research Engineer positions in Data Science/ AI

The Interventional Neuropsychological Team (NPI, Inserm U955, ENS de Paris) directed by Pr. Anne Catherine Bachoud-Lévi and dedicated to the understanding of cognitive functions and related deficits in neurodegenerative diseases, is looking for 2 Post-Doc/ Research Engineers for a project with a mix of expertise in cognitive science, machine learning and speech and language technology.

 

Field of research : Machine learning, cognition, neurosciences, language

Required skills : Machine learning, speech/language processing, statistical analyses

Required qualities : Capacity to work within multidisciplinary teams, interest in clinical applications.

 

More details

Created: 13 September 2021

EATRIS is looking for a Senior Business Strategy Developer

EATRIS, the European Infrastructure for Translational Medicine, is looking for a Senior Business Strategy Developer, to develop a business strategy and set up an operational entity in the context of the European Platform for Neurodegenerative Diseases (EPND), a new project funded by the Innovative Medicines Initiative (IMI).

✔ 32-40 hours a week
✔ Starting date: asap
✔ Secondment from EATRIS institutions possible


Applications will be reviewed upon submission and suitable applicants may be contacted for interview prior to the closing date (September 15).

More details on the EATRIS website jobs listing, Twitter, LinkedIn and Facebook.

 

Created: 17 August 2021

Annual meeting of the Glial Cell Club, organized in collaboration with NeurATRIS

Annual meeting of the French Glial Cell Club, organized from the 18th to 22th of October 2021, in collaboration with NeurATRIS

 

This virtual meeting spread over 5 afternoons in October 2021, offers a very complete coverage and broad of the blooming field of glia research, through 2 plenary lectures, 5 symposia, 2 flash talk sessions for students and post-docs, 2 poster sessions and the general assembly. It will bring together scientists who are experts in the field of glial cell biology from France, the United Kingdom, Germany and Spain.

 

Designed to be a lively and stimulating forum for researchers and students from academia or industry, this meeting will be a real opportunity to learn more about glial cells and state-of-the-art techniques to study them. Young researchers will have the opportunity to present their work as a talk selected on abstract, a flash talk to introduce their poster or a virtual poster.

 

More information

Registrations

Created: 17 August 2021

Translational Neuroscience Day 2021

“Translational Neuroscience Day” is back for its fourth edition organized by NeurATRIS and Celphedia on December 10, 2021, in Paris.

 

This new free edition aims at gathering experts in neurodegenerative diseases with a focus on animal models in Neuroscience Translational Research. Besides, you will be able to interact with all key actors in the field: researchers, clinicians, TTO, biotech, and pharmaceutical companies. This event will also highlight young researcher skills.

 

You could attend in-person as well as online. So, take the opportunity to participate to 3 events in one:

 - Hear KOLs from Academia and Industry in plenary and round table sessions and young researchers introducing their work in posters and “my thesis in 180 sec”.

 - Initiate R&D collaborative projects during digital B2B meetings

 - Increase your network with the virtual poster session

 

More details on program and registration are coming soon.

Created: 23 June 2021

NeurATRIS is co-organizing a workshop on diffusion MR spectroscopy

Lorentz Workshop: Best practices & tools for Diffusion MR Spectrometry

As part of its training support, NeurATRIS is co-organizing a 5-day workshop, dedicated to diffusion NMR spectrometry.

This workshop will take place from September 20 to 24, 2021, in Leiden, Netherlands.

It aims at making DW-MRS more accessible to the MR research community at large by:

(1) Launching a user-friendly open-source platform that will be used to process, analyze, and model experimental data acquired at different sites / vendor scanners / magnetic fields.

(2) Initiating a data repository attached to the open-platform to widen the accessibility of DW-MRS data. It will also contain a description of acquisition protocols, and contact of researchers working in the field.

(3) Writing a ‘consensus paper’ summarizing practical principles of DW-MRS and providing protocol recommendations for different users ’goals, with a description of the novel open-source platform

Find all the information here: https://www.lorentzcenter.nl/best-practices-en-tools-for-diffusion-mr-spectroscopy.html

Created: 02 June 2021

NeurATRIS supports Glia 2021

The European Meeting on Glial Cells in Health and Disease is a reference meeting in the field of neuroscience, with both an educational vocation for young researchers through thematic courses and workshops, and a vocation of exchange and high quality scientific interaction on glial cells.

The scientific program begins with a day of classes intended for students and young researchers wishing to familiarize themselves with the theme of glial cells. It continues with 7 plenary presentations, 30 symposia and thematic workshops, dealing with different aspects of glial cells and their implications in neurodegenerative pathologies.

This year it will take place fully online from July 5 to 9, with the support of NeurATRIS. For more information, do not hesitate to consult the meeting website.

Created: 31 May 2021

NeurATRIS supports NeuroFrance 2021

Société des Neurosciences - Accueil | Facebook

The next NeuroFrance conference will take place entirely online, from May 19 to 21, 2021, with the support of NeurATRIS. You can visit us on our virtual booth, as well as during the symposium entitled "New insights into pathophysiology of neurodevelopmental disorders", supported by NeurATRIS and chaired by Pierre Gressens, member of NeurATRIS. Find all the information here: https://www.neurosciences.asso.fr/SN21/

Created: 31 May 2021

ADVANCE Online Course on ATMP Development

ADVANCE is a 30-month EU training project, supported by Erasmus Plus fund with the objective to develop a 3-stage learning programme to support early-career biomedical scientists in developing currently missing scientific knowledge, transversal skills and competences to meet the key challenge areas existing in the ATMP development cycle. 

The ADVANCE online course launched on December 1st2020 and is completely open and free of charge to anyone interested in the ATMPs development topic. The course consists of ca. 7 hours of interactive lectures and nearly 20 hours of independent hands-on and reading assignments. It is all self-paced, and participants can move through the course as their schedule allows. 

This online course is divided into 4 Units representing the key challenges of the ATMPs development cycle: Scientific, Manufacturing, Reimbursement and Regulatory. You will hear 12 experts across academia, industry, regulatory sector and patient organisation discuss the key aspects in the ATMP development pipeline. The lectures are interspersed with questions to help participants stay engaged and think along. 

If you are interested in learning more about the ADVANCE Project and what else it has to offer, visit the website and follow it on LinkedIn and Twitter.   

ONLINE COURSE: Register Here! 

Created: 01 December 2020

Neuroscience webinar: Innovating therapies for glial cells related diseases

With the help of NeurATRIS and EATRIS, the French Club of Glial Cells offers a mini-symposium on innovating therapies for glial cells related diseases on November 25, 2020 at 14:00 CET.

The diseases of the nervous system including tumors are among the most dreadful diseases in humans. While the final outcome of these diseases is almost invariably due to neuronal dysfunction and death, glial cells often appear to be at the origin or to largely participate to the neuron unsettling. Thus, designing therapies directly targeting glial cells is highly relevant for the large majority of diseases of the central and peripheral nervous system (CNS/PNS).

As glial cells provide an undeniable and significant support to neuron function and survival, an exciting novel way to tackle nervous system diseases is to design therapies that will modify, improve or sustain this support in order to prevent neuronal cell dysfunction or death.

In this webinar, 3 reknowned speakers will illustrate this strategy using various technological approaches and treatments in diverse types of glial-cells related pathologies of the CNS and PNS.

Created: 04 November 2020
Read more: Neuroscience webinar: Innovating therapies for glial cells related diseases

Neuroscience webinar: The role of microglia in health and disease

 

With the help of NeurATRIS and EATRIS, the GDR Microglia and Neuroinflammation offers a mini-symposium on the role of glial cells in health and disease on December 3, 2020 at 14:00 CET.

As microglia were found to play major role in CNS development and interacts with neurons in the healthy brain, an exciting novel way to tackle nervous system diseases is to better understand how microglia during neuroinflammation contribute to neuronal cell dysfunction or death. In this symposium, we propose to apprehend the role of microglial cells in early stage of CNS diseases through various CNS pathological models. The goal is to offer a large enough diversity of speakers to be attractive for a large amount of neuroscientists interested in the fields of microglia, neuroinflammation and neurodegeneration.

Speakers:

  • Rosa Paolicelli (Université de Lausanne, Switzerland): “The many roles of microglia in neurodegeneration”
  • Juliette Van Steenwinckel (Université Paris Diderot, France) “Microglial perturbation in neurodevelopmental disorders induced by early exposure to inflammation”
  • Pierre Szepetowski / Sylvian Bauer (INMED, France) “Early cellular and molecular alterations in cytomegalovirus infection of the fetal brain: microglia and chemokines as therapeutic targets?”

REGISTER HERE

More information about the program…

Rosa C. Paolicelli
Department of Biomedical Sciences, University of Lausanne
The many roles of microglia in neurodegeneration

Abstract: Microglia are implicated in a variety of functions in the central nervous system, ranging from shaping neural circuits during early brain development, to surveying the brain parenchyma, and providing trophic support to neurons across the entire lifespan. In neurodegeneration, microglia have been considered for long time mere bystanders, accompanying and worsening neuronal damage. However, recent evidence indicates that microglia can causally contribute to neurodegenerative diseases, and that their dysfunction can even be at the origin of the pathology. In fact, the broad range of physiological roles microglia play in the healthy brain suggest that faulty microglia can initiate neurodegeneration through several possible mechanisms. In particular, in this webinar, we will discuss how dysfunctional synaptic pruning by microglia significantly affects synaptic function, thus putting microglia center stage in the pathogenesis of brain disorders.

Juliette Van Steenwinckel
NeuroDiderot laboratory (UMR1141 INSERM/University of Paris)
Microglial perturbation in neurodevelopmental disorders induced by early exposure to inflammation.

Abstract: Perinatal inflammation is the leading cause of neurodevelopmental injuries including periventricular white matter injury (PWMI), in the premature newborn. Brain inflammation alters development through neuroinflammatory processes including activation of homeostatic microglia toward a pro-inflammatory and neurotoxic phenotype causing white matter defect. Investigating immune regulators of microglial activation in model of WMI in mice pups could be an effective strategy to prevent PWMI. We presented here an in-depth analysis of microglial activation and phenotype in our model and an original neuroprotective approach employing 3DNA nanocarriers as a cargo to target these regulators specifically in microglia allowing to alleviate neuroinflammatory processes and improve myelination reducing the incidence and severity of perinatal brain injuries.

Pierre Szepetowski / Sylvian Bauer
Mediterranean Institute of Neurobiology (INMED), INSERM, Aix-Marseille University.
Cytomegalovirus Infection of the Rat Developing Brain in Utero: Fetal Microglia and a Viral Chemokine as Targets against Neuropathogenesis (Part I and II)

Abstract: Congenital cytomegalovirus (CMV) infections of the brain are one leading cause of human neurodevelopmental disorders. Despite their frequency and severity, neuropathogenesis remains elusive and no satisfactory therapy is available. In the past years, studies in rodent models have helped in identifying various possible pathogenic processes that included immune alterations. More pathophysiological insights, particularly into the early events following CMV infection of the developing brain, are needed. To reach this aim, we have designed and studied a model of CMV infection of the rat developing brain in utero. In this model, the postnatal manifestations seen in CMV-infected pups recapitulated several aspects of the human disease. Brain immune alterations were detected at the cellular and molecular levels. Recent past as well as ongoing experiments indicate that fetal microglia on the one hand, and a chemokine encoded by the CMV genome on the other hand, might play pivotal roles in neuropathogenesis. These findings might provide proof-of-principle towards the future design of approvable therapeutic options.

Created: 04 November 2020

CoVid19 policy support paper from the 3 european medical research infrastructures

The three European Medical Research Infrastructures (EATRIS, BBMRI and ECRIN) have written a short policy support paper with concrete suggestions on optimising the research process for robust, reproducible and actionable results to tackle the challenges of the COVID-19 pandemic.

These suggestions would be important to reinforce a pandemic preparedness strategy strengthening our capacities to face potential future outbreaks of the disease. 

Here is the link for the document: https://bit.ly/2Al8QUK

Created: 05 June 2020

NeurATRIS at BIO 2020

Do not miss the opportunity to know NeurATRIS better at the international partnering event BIO digital on June 8-12, 2020 ! Ali Aït-Ikhlef, our partnership manager, will be virtually there all the week. Contact him to set up a meeting at ali(dot)ait-ikhlef (at) neuratris(dot)com

 

Ali Ait-Ikhlef NeurATRIS

Created: 28 May 2020

EATRIS response to the CoVid19 pandemic

FAST ACCESS TO KEY SERVICES AND FACILITIES FOR RESEARCH PROJECTS TO COMBAT COVID-19

EATRIS mission is to accelerate the translation of promising scientific discoveries into benefits for patients. We focus our main activities on bridging the innovation gap between the lab and the clinic and we offer services and expertise to increase chances of research to successfully reach patients.

The EATRIS infrastructure’s resources are therefore highly relevant for the research community in the context of the COVID-19 pandemic, and include numerous following expertise and services.

Created: 01 April 2020
Read more: EATRIS response to the CoVid19 pandemic

CoVid19 : advice for patients with neurodegenerative diseases

Associations are mobilized during the CoVid19 epidemic to help persons with neurodegenerative diseases to face the situation by giving advice for patients and their families.

You can read here the newsletter from Fondation Vaincre Alzheimer, with advice about confinement, hygene measures...

The Michael J Fox Foundation offers a webinar with information about the coronavirus for Parkinson's community.

Stay safe and strong !

Created: 01 April 2020

Open session on Parkinson's disease

Join us for the open session of the HOPE 2020 congress on Thursday, January 30, 2020 at ICM from 6PM ! An inspiring overview of new surgical techniques for Parkinson patients by Professor Stéphane PALFI, a testimony by a patient-expert, more about brain donation and its usefulness for researchers by professor Charles DUYCKAERTS, ...

Created: 23 January 2020

HOPE 2020: Submission and registration are open !

The second edition of the "pHysiopathology of Parkinson's DisEase" (HOPE) conference will be held from 29 to 31 January 2020 at ICM in Paris.

Following the success of the first edition and the very stimulating feedback from participants regarding the latest scientific advances and the integration of basic research into clinical research, we are pleased to invite you to take part in this second edition.

The topics will cover the epigenetic and genetic determinants of Parkinson's disease, their molecular mechanisms and their modelling, in order to better understand the pathophysiology of Parkinson's disease and open pre-clinical, clinical and imaging perspectives.

In addition we propose a workshop the first day on two topics that will be discussed later on during the congress

1) Cellular modelling using microfluidic and stem cell technologies

2) Available imaging tools for cellular models and to humans

 

Submission and registrations are available on the conference website: https://hope2020.sciencesconf.org/

Submission deadline: December 1st, 2019

Registration deadline: January 12, 2020

If you would like to contribute to the organization of this event, we are happily welcoming sponsorship: https://hope2020.sciencesconf.org/resource/sponsors

Created: 25 October 2019

Webinar series on Quality and Reproducibility issues

EATRIS is running a series of webinars in the fall of this year, looking at reproducibility issues experienced during specific phases of the drug development pipeline (screening, preclinical models, biomarker development & analytical platforms, clinical validation). These webinars are developed in close collaboration with other Research Infrastructures (EU-OPENSCREEN, INFRAFRONTIER, BBMRI, ECRIN) and initiatives such as Translation Together.

The webinars will be brought to you by experts in the field and include an audience Q&A session during which attendees can ask questions at the end of the lecture. All webinars will be recorded and available for later viewing.

For more information and registration: https://eatris.eu/insights/webinar-series-quality-reproducibility-issues-drug-development/

Created: 27 September 2019
Read more: Webinar series on Quality and Reproducibility issues

EATRIS-Plus project funded by the European Commission

NeurATRIS is pleased to announce that the ‘EATRIS-Plus’ proposal has been funded by the European Commission under the INFRADEV-3 call, which concerns the development and long sustainability of new pan-European research infrastructures. 

NeurATRIS, as EATRIS French node, is one of 19 partners in the four-year project. The project aims to build capabilities and deliver innovative scientific tools to support the long-term sustainability of EATRIS as one of Europe’s key research infrastructures.

Title of proposal: EATRIS-Plus – Consolidating the capacities of EATRIS-ERIC for personalised medicine

Start date: 2020 (precise date to be confirmed)

Duration: 48 months

Created: 30 August 2019
Read more: EATRIS-Plus project funded by the European Commission
Page 1 of 4
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • End

Contacts
Legals

This website is using Cookies. By navigating, you accept this use.